Bifidobacterium breve

Bifidobacterium breve has been studied in 9 papers since 2022: 2 trials in people, 1 in animals, 1 in cells, 5 reviews; 4 in the past year. Its furthest trials in people are at early phase 1. The newest paper, Oct 22, 2026: “Targeting the gut-brain axis with Bifidobacterium breve in neurodegeneration: A comprehensive narrative review of current evidence in…”.

InterventionEarly phase 1

9 papers study it12 findingsUpdated

MeSH

More supplements

1 new paper in 30 daysSee all 9 papers on bifidobacterium breve

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries; 1 trial, none about aging, 1 with no results posted.

“There were no marked changes in the overall composition of the gut microbiota by the probiotic supplementation.”
Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled TrialJournal of Alzheimer's disease : JAD2022doi:10.3233/jad-220148

1 of its findings points the other way.

Cells and humans: a single group. Worms or flies and mice: nothing yet.
  • 2 independent labs in 2 countries
  • 1 finding against
  • 1 trial, none about aging, 1 with no results posted
  • Funders: Morinaga Milk Industry and 8 more
  • 10 of 10 findings with company ties
  • Human trial2
  • Model organisms1
  • Cells1

Studies in people

2 studies gave bifidobacterium breve to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on knee extension strength

no change: Has no effect on microbiome

Randomized trial24 weeks50 peopleBothapproximately 80 yearsPatients with sarcopeniaNutrients, Sep 20, 2026

no change: Has no effect on cognitive function

down: Decreases brain atrophy

no change: Has no effect on microbiome

Randomized trial24 weeks130 people65–89 yearsOlder adults with suspected MCIJournal of Alzheimer's disease : JAD, Jan 1, 2022

What did studies of bifidobacterium breve find?

8

Studies of bifidobacterium breve measured 8 outcomes, among them cognitive function, microbiome and microbiome composition.

Cognitive function

upin humans2no changein humans1

2 studies
  1. Bifidobacterium breve showed no clear effect on cognitive function in FAS at week 24.

    Human trialin FAS at week 2424 weeksn = 115

  2. Bifidobacterium breve improves cognitive function in humans.

    Human trialprobiotic strain Bifidobacterium breve MCC1274 (A1)24 weeksn = 115

  3. Bifidobacterium breve improves cognitive function in humans (at risk for Alzheimer's disease).

    Reviewat risk for Alzheimer's disease

Microbiome

no changein humans2

2 studies
  1. Bifidobacterium breve showed no clear effect on microbiome in humans.

    Human trial24 weeksn = 50

  2. Bifidobacterium breve showed no clear effect on microbiome in humans.

    Human trialfeces24 weeksn = 130

Microbiome composition

no changein humans2

2 studies
  1. Bifidobacterium breve showed no clear effect on microbiome composition in humans (patients with sarcopenia).

    Human trialpatients with sarcopenia2 × 10 10 cells/day24 weeks

  2. Bifidobacterium breve showed no clear effect on microbiome composition in humans.

    Human trialprobiotic strain Bifidobacterium breve MCC1274 (A1)24 weeks

More on Microbiome composition

Knee extension strength

no changein humans1

1 study
  1. Bifidobacterium breve showed no clear effect on knee extension strength in humans.

    Human trial24 weeksn = 50

Skin epithelial damage

downin human cells1

1 study
  1. Bifidobacterium breve decreases skin epithelial damage in human cells (skin cleanser-induced skin epithelial damage in ex vivo human skin).

    Cellsskin cleanser-induced skin epithelial damage in ex vivo human skinskin

keratinocyte differentiation

upin human cells1

1 study
  1. Bifidobacterium breve activates keratinocyte differentiation in ex vivo human skin.

    Cellsin ex vivo human skinskin

Wrinkle depth

downin humans1

1 study
  1. Bifidobacterium breve decreases wrinkle depth in humans.

    Review

Brain atrophy

downin humans1

1 study
  1. Bifidobacterium breve decreases brain atrophy in humans.

    Human trialbrain24 weeksn = 89

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 1Nov 2026: 04 papers in 12 months